Deepoxy-deoxynivalenol retains some immune-modulatory properties of the parent molecule deoxynivalenol in piglets
- 199 Downloads
Deoxynivalenol (DON) is the most abundant trichothecene in food and feed. It causes both acute and chronic disorders of the human and animal intestine, liver and the immune system. The structural basis for the toxicity of DON has not been fully elucidated. Using the pig as a target and a model species for human, the toxicity of DON and its deepoxy-metabolite (DOM-1) was compared. Animals were exposed by gavage to 1 and 0.5 nmol toxin/kg b.w./day for 2 and 3 weeks respectively. Whatever the dose/duration, DOM-1 was less toxic than DON in terms of weight gain and emesis. In the 3-week experiment, animals were vaccinated with ovalbumin, and their immune response was analyzed in addition to tissue morphology, biochemistry and hematology. DON impaired the morphology of the jejunum and the ileum, reduced villi height, decreased E-cadherin expression and modified the intestinal expression of cytokines. Similarly, DON induced hepatotoxicity as indicated by the lesion score and the blood biochemistry. By contrast, DOM-1 only induced minimal intestinal toxicity and did not trigger hepatotoxicity. As far as the immune response was concerned, the effects of ingesting DOM-1 were similar to those caused by DON, as measured by histopathology of lymphoid organs, PCNA expression and the specific antibody response. Taken together, these data demonstrated that DOM-1, a microbial detoxification product of DON, was not toxic in the sensitive pig model but retained some immune-modulatory properties of DON, especially its ability to stimulate a specific antibody response during a vaccination protocol.
KeywordsModified mycotoxins Epoxy group In vivo Immune response Pig
A. Pierron was supported by fellowship from CIFRE (2012/0572, jointly financed by the BIOMIN Holding GmbH, Association Nationale de la Recherche Technique and INRA). The authors thank Drs. Alassane-Kpembi and Payros for helpful discussion.
Compliance with ethical standards
Conflict of interest
The authors declare no conflicts of interest during experimental work reported here.
Supplementary material 2 (MP4 146153 KB)
- Alassane-Kpembi I, Gerez JR, Cossalter AM, Neves M, Laffitte J, Naylies C et al (2017a) Intestinal toxicity of the type B trichothecene mycotoxin fusarenon-X: whole transcriptome profiling reveals new signaling pathways. Sci Rep 7:7530. https://doi.org/10.1038/s41598-017-07155-2 CrossRefPubMedPubMedCentralGoogle Scholar
- Alassane-Kpembi I, Puel O, Pinton P, Cossalter AM, Chou TC, Oswald IP (2017b) Co-exposure to low doses of the food contaminants deoxynivalenol and nivalenol has a synergistic inflammatory effect on intestinal explants. Arch Toxicol 91:2677–2687. https://doi.org/10.1007/s00204-016-1902-9 CrossRefPubMedGoogle Scholar
- Awad WA, Ghareeb K, Dadak A, Hess M, Bohm J (2014) Single and combined effects of deoxynivalenol mycotoxin and a microbial feed additive on lymphocyte DNA damage and oxidative stress in broiler chickens. PLoS One 9:e88028. https://doi.org/10.1371/journal.pone.0100907 CrossRefPubMedPubMedCentralGoogle Scholar
- Bracarense AP, Lucioli J, Grenier B, Drociunas Pacheco G, Moll WD, Schatzmayr G et al (2012) Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. Br J Nutr 107:1776–1786. https://doi.org/10.1017/S0007114511004946 CrossRefPubMedGoogle Scholar
- Devriendt B, Gallois M, Verdonck F, Wache Y, Bimczok D, Oswald IP et al (2009) The food contaminant fumonisin B(1) reduces the maturation of porcine CD11R1(+) intestinal antigen presenting cells and antigen-specific immune responses, leading to a prolonged intestinal ETEC infection. Vet Res 40:40. https://doi.org/10.1051/vetres/2009023 CrossRefPubMedPubMedCentralGoogle Scholar
- Gerez JR, Desto SS, Bracarense A (2016) Deoxynivalenol induces toxic effects in the ovaries of pigs: an ex vivo approach. Theriogenology 90:94–100. https://doi.org/10.1016/j.theriogenology.2016.10.023 CrossRefPubMedGoogle Scholar
- Girish CK, Smith TK, Boermans HJ, Anil Kumar P, Girgis GN (2010) Effects of dietary Fusarium mycotoxins on intestinal lymphocyte subset populations, cell proliferation and histological changes in avian lymphoid organs. Food Chem Toxicol 48:3000–3007. https://doi.org/10.1016/j.fct.2010.07.040 CrossRefPubMedGoogle Scholar
- Grenier B, Bracarense AP, Schwartz HE, Trumel C, Cossalter AM, Schatzmayr G et al (2012) The low intestinal and hepatic toxicity of hydrolyzed fumonisin B(1) correlates with its inability to alter the metabolism of sphingolipids. Biochem Pharmacol 83:1465–1473. https://doi.org/10.1016/j.bcp.2012.02.007 CrossRefPubMedGoogle Scholar
- Li XZ, Zhu C, de Lange CF, Zhou T, He J, Yu H et al (2011) Efficacy of detoxification of deoxynivalenol-contaminated corn by Bacillus sp. LS100 in reducing the adverse effects of the mycotoxin on swine growth performance. Food Addit Contam Part A 28:894–901. https://doi.org/10.1080/19440049.2011.576402 CrossRefGoogle Scholar
- Lucioli J, Pinton P, Callu P, Laffitte J, Grosjean F, Kolf-Clauw M et al (2013) The food contaminant deoxynivalenol activates the mitogen activated protein kinases in the intestine: interest of ex vivo models as an alternative to in vivo experiments. Toxicon 66:31–36. https://doi.org/10.1016/j.toxicon.2013.01.024 CrossRefPubMedGoogle Scholar
- Maresca M, Yahi N, Younes-Sakr L, Boyron M, Caporiccio B, Fantini J (2008) Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteria. Toxicol Appl Pharmacol 228:84–92. https://doi.org/10.1016/j.taap.2007.11.013 CrossRefPubMedGoogle Scholar
- Mayer E, Novak B, Springler A, Schwartz-Zimmermann HE, Nagl V, Reisinger N et al (2017) Effects of deoxynivalenol (DON) and its microbial biotransformation product deepoxy-deoxynivalenol (DOM-1) on a trout, pig, mouse, and human cell line. Mycotoxin Res 33:297–308. https://doi.org/10.1007/s12550-017-0289-7 CrossRefPubMedPubMedCentralGoogle Scholar
- Mikami O, Yamaguchi H, Murata H, Nakajima Y, Miyazaki S (2010) Induction of apoptotic lesions in liver and lymphoid tissues and modulation of cytokine mRNA expression by acute exposure to deoxynivalenol in piglets. J Vet Sci 11:107–113. https://doi.org/10.4142/jvs.2010.11.2.107 CrossRefPubMedPubMedCentralGoogle Scholar
- Pinton P, Tsybulskyy D, Lucioli J, Laffitte J, Callu P, Lyazhri F et al (2012) Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases. Toxicol Sci 130:180–190. https://doi.org/10.1093/toxsci/kfs239 CrossRefPubMedGoogle Scholar
- Springler A, Hessenberger S, Reisinger N, Kern C, Nagl V, Schatzmayr G et al (2017) Deoxynivalenol and its metabolite deepoxy-deoxynivalenol: multi-parameter analysis for the evaluation of cytotoxicity and cellular effects. Mycotoxin Res 33:25–37. https://doi.org/10.1007/s12550-016-0260-z CrossRefPubMedGoogle Scholar